Twenty-five % of institutions with accredited U ed causes and treatment.

Twenty-five % of institutions with accredited U.S ed causes and treatment . Nephrology training programs not accredited geriatric training programs, but the Accreditation Council for Graduate Medical Education has mandated that fellows receive formal training in geriatric nephrology. Nephrology.line curriculum will serve as a primary source of educational material for geriatric nephrology training nationwide.

A grant was provided by the Association of Specialty Professors for this curriculum, which includes 38 chapters on various aspects of geriatric nephrology. The online resources will be expanded over the coming months, Power Point PowerPoint presentations that posted the information in. The entire curriculum will be freely available for anyone to access and use. Of nephrology.erstands the importance of treating of geriatric population Nephrology and also works with ASP to three additional efforts ASN partners with the Association of Specialty Professors to provide the ASN – ASP Junior Development Grant in Geriatric Nephrology. Since 2003, ASN and ASP have more than seven junior nephrologists who have decided to have focused their research career to issues related to the geriatric aspects of nephrology funded. In 2008 there were two recipients of this grant, Steven G. And Lisa M. DO NanoVic.

Dacarbazine, has proven the standard chemotherapy melanoma at for decades when alone when used alone. Its performance, Randy Burd, assistant professor in nutrition and a member of AND OTHERS BIO5 institutes, a cell – testing the drug and its new analog temozolomide is in combination with various bioactive compounds more response rates at melanoma cell cultures is to win. ‘After working with COX – 2 inhibitors – which had complication – we started views of quinones, which exist in nature, such as pigments, vitamin biochemistry backbones and plant products, and it we analyzed enzyme participate in its activation ‘said Burd.

Is used for the successful compounds as quercetin in the melanoma study, the researchers have for to change in available drugs , making stronger the connection, and it repeating she into clinical trials. – ‘We are looking expressed, such that a specific treatment a specific therapy well in which enzymes at different tumors,’Burd said.